Paradigmenwechsel in der Therapieempfehlung des Asthma bronchiale

  title={Paradigmenwechsel in der Therapieempfehlung des Asthma bronchiale},
  author={Adrian Gillissen and Hubert Wirtz and Gerhard Hoheisel},
  journal={Medizinische Klinik},
ZusammenfassungDie Leitlinie der Global Initiative for Asthma (GINA) 2006 beinhaltet weitreichende Neuerungen in der Asthmatherapie und -kontrolle. Während sich bisher die Dosis und die Auswahl der empfohlenen Medikamente am Schweregrad orientierten, wird jetzt ein flexibles Schema empfohlen, das dem behandelnden Arzt große Freiheiten in der Substanzauswahl gibt. Das Nebeneinander der dennoch weiterhin bestehenden vierstufigen Schweregradeinteilung und des neuen fünfstufigen Therapieschemas… 
Asthma bei Erwachsenen
Full reversibility after application of inhaled rapid-acting β2-agonist is a universal and defining feature of asthma and uncharacteristic for COPD.
Journal Club
Athleten in Ausdauersportarten leiden überproportional häufig an einer bronchialen Hyperreagibilität (BHR) oder einem Asthma bronchiale. Viele Gründe wurden dafür angenommen, vor allem die
Die Impulsoszillometrie in der Schweregraddiagnostik obstruktiver Lungenerkrankungen 1,2,3 Impulse Oscillometry in the Diagnosis of the Severity of Obstructive Pulmonary Disease
Bronchial obstruction can reliably be diagnosed by IOS when, in cases of severe obstruction, more complex parameters like FDR and X5 are included, and the parameters R5, X5, and Zrs showed a tendency to underestimate the degree of obstruction.
Asthma control in asthmatic patients treated for lung cancer.
The observations indicate that asthmatic patients with acquisition or progression of NSCLC may have worsening of their asthma control status, and the Th2 pathway in lung cancer may be a contributing factor in asthma control, another Th2 predominant disorder.
Impacto das crises de sibilância em crianças de 0 a 3 anos de uma área de baixa renda no sul do Brasil Impact of wheezing episodes in children 0 to 3 years old from a low-income area in Southern Brazil
The prevalence of wheezing on young children is high in a low-income area from Porto Alegre, and the symptoms usually occur during the first two years of life, demonstrating the impact of obstructive lung disease in this age group.
American Thoracic Society Annual International Congress
The general impression from the meeting was that the focus this year shifted more to basic research of pulmonary diseases, new diagnostic techniques and tools to approximate disease progression rather than presenting new drugs for treatment.
[Pneumology 2009. Diseases of the lung and air passages 2009].


Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
  • G. D'Amato
  • Medicine, Biology
    Expert opinion on biological therapy
  • 2003
The anti-IgE approach to asthma treatment has a number of further potential advantages, such as the treatment of other concomitant atopic diseases, regardless of the type of allergic sensitisation (seasonal or perennial).
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.
It is concluded that reducing AHR in conjunction with optimizing symptoms and lung function leads to more effective control of asthma while alleviating chronic airways inflammation, implying a role for the monitoring of AHR or other surrogate markers of inflammation in the long-term management of asthma.
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.
Omalizumab reduces the rate of serious asthma exacerbations and the need for unscheduled outpatient visits, emergency room treatment, and hospitalization in patients with moderate-to-severe allergic asthma.
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
With the use of FE(NO) measurements, maintenance doses of inhaled corticosteroids may be significantly reduced without compromising asthma control.
Breaking new ground: challenging existing asthma guidelines
The limitations of current asthma guidelines are reviewed and important issues and remaining questions regarding asthma guidelines for use are described, particularly in primary care.
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
Subgroup analyses suggest the risk may be greater in African Americans compared with Caucasian subjects and whether this risk is due to factors including but not limited to a physiologic treatment effect, genetic factors, or patient behaviors leading to poor outcomes remains unknown.
Development and validation of a questionnaire to measure asthma control.
The Asthma Control Questionnaire has strong evaluative and discriminative properties and can be used with confidence to measure asthma control.
Meta-Analysis: Effect of Long-Acting -Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths
The conclusion from these studies was that long-acting -agonists improve asthma control, and this study followed more than 26000 participants for 6 months and found a 4-fold increased risk for asthma-related deaths.
How should we quantify asthma control? A proposal.
A simple easy-to-use asthma control scoring system based on a percentage of optimal control that could be a simple tool that is potentially useful both for the clinician and for research purposes, to quantify global or specific aspects of asthma control.
Low dose inhaled corticosteroids and the prevention of death from asthma.
A nested case-control study in which subjects who died of asthma were matched with controls within the cohort according to the length of follow-up at the time of death of the case patient (the index date), the date of study entry, and the severity of asthma.